← all drugs
Lasmiditan Succinate Tablet
being discontinued · Neurology · Snapshot: 2026-10-09
- Manufacturers listed
- Eli Lilly and Co.
- Machine-readable
- JSON for this drug
Presentations (6)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Reyvow, Tablet, 100 mg (NDC 0002-4491-61) | Eli Lilly and Co. | unknown | 11/03/2025 |
| Reyvow, Tablet, 50 mg (NDC 0002-4312-08) | Eli Lilly and Co. | unknown | 11/03/2025 |
| Reyvow, Tablet, 50 mg (NDC 0002-4312-61) | Eli Lilly and Co. | unknown | 11/03/2025 |
| Reyvow, Tablet, 50 mg (NDC 0002-4312-62) | Eli Lilly and Co. | unknown | 11/03/2025 |
| Reyvow, Tablet, 100 mg (NDC 0002-4491-62) | Eli Lilly and Co. | unknown | 11/03/2025 |
| Reyvow, Tablet, 100 mg (NDC 0002-4491-08) | Eli Lilly and Co. | unknown | 11/03/2025 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive). No change to its FDA listing has been observed since.
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.